7Baggers
Quarterly
Annual
    Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 
      
    		                
      cash flows from operating activities:
    		                
      net income
    		-17,792,000 -9,265,000 -155,093,000 -84,717,000 -187,824,000 -306,187,000 -12,718,000 -13,362,000 -248,688,000 -11,977,000 -15,600,000 6,735,000 -6,354,000 -9,579,000 -13,057,000 -14,764,000 
      adjustments to reconcile net income to net cash from operating activities:
    		                
      depreciation and amortization
    		853,000 868,000 591,000 526,000 562,000 603,000 554,000 562,000 432,000 446,000 513,000 472,000 469,000 727,000 525,000 558,000 
      amortization of intangible assets
    		13,207,000 13,470,000 13,226,000 12,606,000 12,501,000 12,185,000 12,130,000 12,439,000 12,595,000 12,332,000 12,431,000 12,214,000 12,723,000 15,047,000 14,727,000 14,679,000 
      amortization of deferred contract costs
    		3,996,000 3,988,000 3,947,000 3,978,000 3,943,000 3,828,000 3,692,000 3,488,000 3,445,000 3,170,000 2,860,000 2,542,000 2,283,000 2,116,000 1,875,000 1,598,000 
      equity-based compensation
    		6,684,000 6,980,000 7,319,000 7,365,000 6,296,000 8,842,000 15,582,000 13,254,000 11,994,000 12,363,000 11,128,000 11,424,000 9,133,000 9,005,000 6,872,000 5,619,000 
      amortization of debt issuance costs
    		131,000 123,000 126,000 175,000 176,000 175,000 176,000 175,000 176,000 175,000 176,000 175,000 176,000 175,000 176,000 176,000 
      write-off of deferred offering costs
    		                
      (recovery of) benefit from doubtful accounts receivable
    		-314,000                
      loss on partial extinguishment of debt
    		0 0 507,000              
      non-cash restructuring charges
    		160,000 0 192,000     0 -143,000        
      goodwill impairment charges
    		0 0 176,531,000 97,060,000             
      tra remeasurement
    		                
      changes in fair value of contingent consideration
    		-3,280,000 0 -690,000 1,460,000 -3,510,000 0 270,000         595,000 
      deferred income taxes
    		299,000 398,000 -11,007,000 -6,061,000 -13,774,000 -21,988,000 -847,000 1,015,000 -17,304,000 -1,651,000 -773,000 -17,087,000 -42,000 -233,000 69,000  
      changes in operating assets and liabilities:
    		                
      accounts receivable
    		3,477,000 5,523,000 10,351,000 -17,455,000 7,948,000 12,201,000 2,999,000 -18,559,000 5,486,000 6,918,000 6,966,000 -25,676,000 -2,816,000 6,744,000 8,526,000 -15,905,000 
      prepaid expenses and other assets
    		749,000 1,453,000 -5,683,000 -627,000 -2,947,000 -2,859,000 -1,399,000          
      deferred contract costs
    		-3,117,000 -2,465,000 -3,794,000 -4,481,000 -2,596,000 -2,980,000 -2,699,000 -5,770,000 -3,913,000 -5,086,000 -4,021,000 -5,182,000 -3,224,000 -3,547,000 -3,299,000 -5,398,000 
      contingent consideration
    		   0 0 0 -602,000     0 0 0 -6,400,000  
      accounts payable, accrued expenses, and other liabilities
    		12,498,000 -3,400,000 -8,745,000 -285,000 5,116,000 -2,058,000 -8,231,000  1,434,000 1,271,000 -4,294,000      
      deferred revenue
    		-9,471,000 -11,091,000 19,094,000 7,157,000 -10,848,000 -11,026,000 9,738,000 7,533,000 -11,869,000 -7,813,000 5,569,000 15,714,000 -4,702,000 -4,571,000 6,249,000 13,938,000 
      net cash from operating activities
    		15,687,000 9,304,000 26,066,000 8,135,000 19,432,000 14,040,000 16,589,000 4,709,000 9,487,000 12,037,000 14,957,000 -4,220,000 10,685,000 15,481,000 13,633,000 4,219,000 
      capex
    		-2,281,000 -2,293,000 -7,706,000 -10,901,000 -767,000 -410,000 -266,000 -594,000 -305,000 -740,000 -1,338,000 0 -1,878,000 -783,000 -794,000 0 
      free cash flows
    		13,406,000 7,011,000 18,360,000 -2,766,000 18,665,000 13,630,000 16,323,000 4,115,000 9,182,000 11,297,000 13,619,000 -4,220,000 8,807,000 14,698,000 12,839,000 4,219,000 
      cash flows from investing activities:
    		                
      purchases of property, equipment, and other assets
    		-2,281,000 -2,293,000 -7,706,000 -10,901,000 -767,000 -410,000 -266,000 -594,000 -305,000 -740,000 -1,338,000      
      purchases of short-term investments
    		0 -52,065,000 -12,000,000 -111,634,000 -68,724,000 -40,120,000 -83,826,000 -45,595,000 -80,814,000 -42,547,000 -90,252,000 -120,695,000 -54,309,000 -53,398,000 -109,559,000  
      maturities of short-term investments
    		26,422,000 44,196,000 103,251,000 96,265,000 78,452,000 55,464,000 73,588,000 100,596,000 72,083,000 44,627,000 58,120,000 57,680,000 52,000,000    
      cash paid for acquisitions, net of cash acquired
    		    0 0 -13,530,000      203,000 0 -56,499,000  
      net cash from investing activities
    		24,141,000 -10,162,000 83,545,000 -26,270,000 8,961,000 14,934,000 -24,034,000 54,407,000 -54,059,000 1,340,000 -33,470,000 -67,886,000 -3,984,000 -10,181,000 -166,852,000 -41,069,000 
      cash flows from financing activities:
    		                
      repayments of term loan
    		-2,187,000 -2,188,000 -246,250,000              
      proceeds from term loan
    		0 0 175,000,000             0 
      payments of debt issuance costs
    		0 0 -1,660,000              
      taxes paid related to net share settlement of equity awards
    		-1,063,000 -609,000 -1,874,000 -278,000 -495,000 -969,000 -5,806,000 -1,035,000 -782,000 -1,085,000 -1,530,000 -1,371,000     
      repurchases of class a common stock
    		-9,221,000 -19,076,000 -21,155,000 -7,329,000 -8,034,000            
      payments of contingent consideration
    		   0 0            
      payments under tra
    		                
      member distributions
    		0   -2,324,000 -98,000   -1,589,000 -7,866,000   -5,932,000 -1,652,000 -5,029,000 -258,000 -989,000 
      net cash from financing activities
    		-12,471,000 -24,700,000 -109,706,000 -13,368,000 -12,065,000 -14,122,000 -17,194,000 -6,062,000 -10,366,000 -5,631,000 -3,525,000 -9,457,000 -6,115,000 -6,748,000 -4,376,000 234,677,000 
      net increase in cash and cash equivalents
    		           -81,563,000 586,000 -1,448,000 -157,595,000 197,827,000 
      effect of exchange rate changes on cash and cash equivalents
    		-24,000 443,000 816,000 -728,000 380,000 55,000 -343,000 462,000 13,000 -322,000 65,000 -331,000 40,000 -145,000 -108,000 -81,000 
      cash and cash equivalents, beginning of period
    		0 0 105,378,000  0 0 130,976,000  0 0 146,934,000  0 0 387,498,000 0 
      cash and cash equivalents, end of period
    		27,333,000 -25,115,000 106,099,000  16,708,000 14,907,000 105,994,000  -54,925,000 7,424,000 124,961,000  626,000 -1,593,000 229,795,000 197,746,000 
      supplemental cash flow disclosures:
    		                
      cash paid during the period for:
    		                
      interest
    		2,870,000 2,959,000 2,242,000  3,654,000 3,590,000 3,642,000  3,681,000 3,616,000 3,475,000  2,898,000 2,579,000 1,771,000  
      income taxes
    		176,000 0 32,000      0 57,000 79,000      
      acquisitions:
    		                
      net assets acquired, net of cash acquired
    		    0 0 13,675,000      -203,000 0 97,499,000  
      working capital adjustment receivable
    		    0 0 -145,000          
      net cash paid for acquisitions
    		    0 0 13,530,000      -203,000 0 56,499,000  
      supplemental disclosure of non-cash investing activities:
    		                
      capital expenditures included in accounts payable and accrued expenses and other liabilities
    		1,764,000 -446,000 5,393,000  -6,000            
      tax receivable agreement remeasurement
    		 2,901,000 -20,664,000 -8,758,000 -24,183,000 -41,701,000 -2,267,000 1,507,000 -29,675,000 1,079,000 3,619,000 -1,078,000 -5,153,000 -3,391,000 248,000  
      payments under tax receivable agreement
    		 0 -13,767,000 0 0 0 -6,950,000 0 0 0 -246,000      
      net decrease in cash and cash equivalents
    		 -25,558,000 -95,000 -31,503,000 16,328,000 14,852,000 -24,639,000  -54,938,000 7,746,000 -22,038,000      
      (benefit from) benefit from doubtful accounts receivable
    		  -142,000              
      cash flows used in financing activities:
    		                
      benefit from bad debt expense
    		                
      cash paid for acquisitions and investments, net of cash acquired
    		                
      repayments of term loans
    		   -3,437,000 -3,438,000 -3,437,000 -3,438,000  -1,718,000 -1,719,000 -1,719,000  -1,718,000 -1,719,000 -1,719,000  
      payments of equity offering issuance costs
    		       0 0 0 -30,000 -435,000 0 0 -1,299,000  
      cash and cash equivalents, beginning of year
    		                
      cash and cash equivalents, end of year
    		                
      benefit from doubtful accounts receivable
    		    419,000 317,000 211,000 554,000 354,000 444,000 22,000    9,000 556,000 
      non-cash impairment charges related to office leases
    		    0            
      goodwill impairment charge
    		       0         
      payment of contingent consideration
    		      -1,000,000     0 0 0 -1,100,000 0 
      capital expenditures included in accrued expenses and other liabilities
    		                
      loss on extinguishment of debt
    		               0 
      accounts payable, accrued expenses and other liabilities
    		                
      repayments of term loans and delayed draw term loan
    		                
      payment of debt issuance costs
    		               0 
      proceeds from equity offering, net of underwriting discounts
    		                
      repurchase of outstanding equity / definitive opco units
    		                
      member contributions
    		               0 
      prepaid expenses and other current assets
    		        -2,237,000 225,000 -3,796,000 -2,681,000 1,235,000 627,000 692,000 -3,168,000 
      initial cash investment in prior year
    		            0 0 -40,000,000  
      capital expenditures included in accounts payable and accrued expenses
    		                
      supplemental disclosure of non-cash financing activities:
    		                
      unpaid equity offering costs included in accrued expenses
    		                
      capital expenditures included in accrued expenses
    		         -273,000 333,000  1,004,000 0 3,500,000  
      non-cash restructuring charges related to office leases
    		          157,000 0 0    
      noncash paid in-kind interest expense
    		                
      proceeds from delayed draw term loan
    		                
      proceeds from revolving credit facility
    		                
      repayments of revolving credit facility
    		                
      allowance for doubtful accounts
    		            763,000    
      accounts payable, accrued expenses and other current liabilities
    		            6,194,000 1,341,000 -3,579,000 5,053,000 
      cash flows used in investing activities:
    		                
      purchases of property, equipment and other assets
    		            -1,878,000 -783,000 -794,000  
      cash paid for income taxes
    		                
      decrease in accrued purchases of data
    		                
      unpaid public offering costs included in accrued expenses
    		                
      proceeds from equity offerings, net of underwriting discounts
    		                
      repurchase of outstanding equity/definitive opco units
    		                
      noncash paid in kind interest expense
    		                
      payments of ipo issuance costs
    		                
      cash paid for interest
    		                
      net decrease in accrued capital expenditures, including purchases of data
    		                
      increase in unpaid public offering costs
    		                
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.